Patent details

Basic Information

Publication number:

EP3836920

PCT Application Number:

US2019046789

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP198499485

PCT Publication Number:

WO2020037189

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FORMULATIONS OF AG10

French Title of Invention:

FORMULES D'AG10

German Title of Invention:

AG10-FORMULIERUNGEN

SPC Number:

Dates

Filing date:

16/08/2019

Grant date:

01/10/2025

EP Publication Date:

23/06/2021

PCT Publication Date:

20/02/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/10/2025

EP B1 Publication Date:

01/10/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

16/08/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/09/2025

 

 

Name:

Eidos Therapeutics, Inc.

Address:

3160 Porter Drive Suite 250, Palo Alto, CA 94304, United States (US)

Agent

Name:

NLO

From:

28/11/2025

Address:

P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)

To:

Inventor

1

Name:

JERNELIUS, Jesper

Address:

United States (US)

2

Name:

MENNING, Mark Michael

Address:

United States (US)

Priority

Priority Number:

201862765154 P

Priority Date:

17/08/2018

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/415; A61K 9/20;

Publication

European Patent Bulletin

Issue number:

202540

Publication date:

01/10/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/08/2026

Annual Fee Number:

8

Annual Fee Amount:

99 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/11/2025	Power Of Attorney	1
28/11/2025	Outgoing Correspondence	1